These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7742152)

  • 1. The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent.
    Peck RW; Wootton R; Lee DR; Jackson SH; Posner J
    Br J Clin Pharmacol; 1995 Feb; 39(2):143-9. PubMed ID: 7742152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tolerability of single oral doses of 882C87, a potent, new anti-varicella-zoster virus agent, in healthy volunteers.
    Peck RW; Weatherley BC; Wootton R; Crome P; Holdich TA; Posner J
    Antimicrob Agents Chemother; 1995 Jan; 39(1):20-7. PubMed ID: 7695306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary pharmacokinetics and safety of 882C87 in patients with herpes zoster.
    Wood MJ; McKendrick MW; Bannister B; Mandal BK; Peck RW; Crooks RJ
    J Med Virol; 1993; Suppl 1():154-7. PubMed ID: 8245884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of netivudine, a potent anti-varicella zoster virus drug, in patients with renal impairment.
    Fillastre JP; Godin M; Legallicier B; Chretien P; Bidault R; Gillotin C; Wooton R; Posner J; Peck RW
    J Antimicrob Chemother; 1996 May; 37(5):965-74. PubMed ID: 8737146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple dose netivudine, a potent anti-varicella zoster virus agent, in healthy elderly volunteers and patients with shingles.
    Peck RW; Crome P; Wood MJ; McKendrick MW; Bannister B; Mandal BK; Crooks RJ
    J Antimicrob Chemother; 1996 Mar; 37(3):583-97. PubMed ID: 9182115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of dihydropyrimidine dehydrogenase by 5-propynyluracil, a metabolite of the anti-varicella zoster virus agent netivudine.
    Peck R; Wiggs R; Callaghan J; Wootton R; Crome P; Fraser I; Frick L; Posner J
    Clin Pharmacol Ther; 1996 Jan; 59(1):22-31. PubMed ID: 8549030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral bioavailability and anti-simian varicella virus efficacy of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) in monkeys.
    Soike K; Huang JL; Tu JI; Stouffer B; Mitroka JG; Swerdel M; Olsen S; Bonner DP; Tuomari AV; Field AK
    J Infect Dis; 1992 Apr; 165(4):732-6. PubMed ID: 1313071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacology and pharmacokinetics of the anti-hepatitis virus agent 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil in mice and rats.
    Kong XB; Vidal P; Tong WP; Chiang J; Gloff CA; Chou TC
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1472-7. PubMed ID: 1510443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)uracil in woodchucks.
    Witcher JW; Boudinot FD; Baldwin BH; Ascenzi MA; Tennant BC; Du JF; Chu CK
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2184-7. PubMed ID: 9333045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorivudine: a potent inhibitor of varicella zoster virus replication.
    Whitley RJ
    Adv Exp Med Biol; 1996; 394():41-4. PubMed ID: 8815706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H
    Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclovir--and beyond.
    Darby G
    J Int Med Res; 1994; 22 Suppl 1():33A-42A. PubMed ID: 8063023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated sequential trace enrichment of dialysates combined with high-performance liquid chromatography and automated heart-cutting for the determination of the nucleoside 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil and its metabolite 5-propynyluracil in urine.
    Cooper JD; Sheung CT; Buick AR
    J Chromatogr; 1994 Jan; 652(1):15-21. PubMed ID: 8014223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuous oral absorption pharmacokinetic model and bioavailability of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)uracil (L-FMAU) in rats.
    Wright JD; Ma T; Chu CK; Boudinot FD
    Biopharm Drug Dispos; 1996 Apr; 17(3):197-207. PubMed ID: 8983395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).
    Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW
    Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster.
    Yan J; Tyring SK; McCrary MM; Lee PC; Haworth S; Raymond R; Olsen SJ; Diasio RB
    Clin Pharmacol Ther; 1997 May; 61(5):563-73. PubMed ID: 9164418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 1-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-methyluracil (L-FMAU) in rats.
    Wright JD; Ma T; Chu CK; Boudinot FD
    Pharm Res; 1995 Sep; 12(9):1350-3. PubMed ID: 8570534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)-uracil and a metabolite, 5-propynyluracil, in plasma using ASTED (automated sequential trace enrichment of dialysates) combined, on-line, with high-performance liquid chromatography.
    Buick AR; Sheung CT
    J Chromatogr; 1993 Jul; 617(1):65-70. PubMed ID: 8376539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections.
    Feinberg A; Leyland-Jones B; Fanucchi MP; Hancock C; Fox JJ; Watanabe KA; Vidal PM; Williams L; Young CW; Philips FS
    Antimicrob Agents Chemother; 1985 May; 27(5):733-8. PubMed ID: 2990323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH
    Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.